Zobrazeno 1 - 10
of 537
pro vyhledávání: '"Pradelli, L"'
Publikováno v:
ClinicoEconomics and Outcomes Research, Vol Volume 15, Pp 97-109 (2023)
Gianni Ghetti,1 Lorenzo Pradelli,1 Giannis Papageorgiou,2 George Karpouzos,2 Yelda Arikan3 1AdRes Health Economics and Outcome Research, Turin, Italy; 2Boehringer Ingelheim Hellas, Athens, Greece; 3Boehringer Ingelheim, Amsterdam, the NetherlandsCorr
Externí odkaz:
https://doaj.org/article/6b9d6e6df1eb433fb0d98176e5cabaf0
Publikováno v:
ClinicoEconomics and Outcomes Research, Vol Volume 13, Pp 661-671 (2021)
Marco Bellone,1 Lorenzo Pradelli,1 Stefano Molica,2 Adele Emanuela De Francesco,3 Daniela Ghislieri,4 Emanuele Guardalben,5 Antonietta Caputo4 1Department of Health Economics and Outcome Research, AdRes Health Economics and Outcomes Research, Turin,
Externí odkaz:
https://doaj.org/article/340a815a95484415b435f5ca72d30a55
Autor:
Pradelli L, Sinigaglia T, Migliore A, Checchia GA, Franceschi F, Frediani B, Iannone F, Romanini E
Publikováno v:
Therapeutics and Clinical Risk Management, Vol Volume 17, Pp 507-530 (2021)
Lorenzo Pradelli,1 Tiziana Sinigaglia,1 Alberto Migliore,2 Giovanni Antonio Checchia,3 Francesco Franceschi,4 Bruno Frediani,5 Florenzo Iannone,6 Emilio Romanini7 1AdRes HE&OR, Torino, Italy; 2Saint Peter Hospital, Rome, Italy; 3Hospital of Monselice
Externí odkaz:
https://doaj.org/article/92f4a634d1b7492e91211c8cf4fd2070
Publikováno v:
ClinicoEconomics and Outcomes Research, Vol Volume 13, Pp 121-133 (2021)
Gianni Ghetti,1 Maria Claudia D’Avella,2 Lorenzo Pradelli1 1Department of Health Economics and Outcome Research, AdRes, Turin, Italy; 2Department of Market Access, Sanofi, Milan, ItalyCorrespondence: Gianni GhettiDepartment of Health Economics and
Externí odkaz:
https://doaj.org/article/35d9027db1f04c73aea94fc7e7972e05
Publikováno v:
ClinicoEconomics and Outcomes Research, Vol Volume 10, Pp 733-745 (2018)
Massimiliano Povero,1 Antonio Miceli,2,3 Lorenzo Pradelli,1 Matteo Ferrarini,2 Matteo Pinciroli,4 Mattia Glauber2 1AdRes Health Economics and Outcomes Research, Turin, Italy; 2Minimally Invasive Cardiothoracic Department, Istituto Clinico Sant’Ambr
Externí odkaz:
https://doaj.org/article/d408b1c4dcf141cc9f22173a1d758e84
Autor:
Pradelli L, Povero M, Bürkle H, Kampmeier T, Della-Rocca G, Feuersenger A, Baron J, Westphal M
Publikováno v:
ClinicoEconomics and Outcomes Research, Vol Volume 9, Pp 685-698 (2017)
Lorenzo Pradelli,1 Massimiliano Povero,1 Hartmut Bürkle,2 Tim-Gerald Kampmeier,3 Giorgio Della-Rocca,4 Astrid Feuersenger,5 Jean-Francois Baron,6 Martin Westphal5 1AdRes HE&OR, Torino, Italy; 2Department of Anaesthesiology and Critical Care Medicine
Externí odkaz:
https://doaj.org/article/9fdf3c903b16484fb3f5d1a7e6a89a48
Publikováno v:
ClinicoEconomics and Outcomes Research, Vol Volume 9, Pp 547-555 (2017)
Yufei Feng,1 Chao Li,1 Tian Zhang,1 Lorenzo Pradelli2 1Department of Pharmacy, Beijing Hospital, National Center of Gerontology, Beijing, People’s Republic of China; 2AdRes Health Economics and Outcomes Research, Piazza Carlo Emanuele II, Torino, I
Externí odkaz:
https://doaj.org/article/1b96f669807543eeba30d9fa4f82631a
Publikováno v:
Global & Regional Health Technology Assessment, Vol 6, Iss 1 (2019)
Externí odkaz:
https://doaj.org/article/735b9be87fe741e893f75c13460c9ffd
Publikováno v:
Global & Regional Health Technology Assessment, Vol 2019 (2019)
In the randomized, active-controlled, multicenter Phase III open-label ALEX trial, alectinib showed superior efficacy and lower toxicity compared with crizotinib in the primary treatment of anaplastic lymphoma kinase-positive non-small cell lung canc
Externí odkaz:
https://doaj.org/article/b63e6b64abe645efa88c858e6373fcbe
Publikováno v:
ClinicoEconomics and Outcomes Research, Vol 2015, Iss default, Pp 369-375 (2015)
Guo Hao Wu,1 Jian Gao,2 Chun Yan Ji,2 Lorenzo Pradelli,3 Qiu Lei Xi,1 Qiu Lin Zhuang1 1Department of General Surgery, 2Department of Nutrition, Zhongshan Hospital, Fudan University, Shanghai, People's Republic of China; 3AdRes Health Economics and Ou
Externí odkaz:
https://doaj.org/article/25c8a34d92054051b24608a36b175feb